Galvani Bioelectronics, the developer of bioelectronic medicines launched by GlaxoSmithKline and Alphabet’s life science play Verily (formerly Google Life Sciences) in early August, will have a bioelectronic visionary on board. Moncef Slaoui, who expedited GSK investments in the field of bioelectronics, will be the chairman of the new company’s Board of Directors.
Union builder
AppointmentsSwedish Gyros Protein Technologies AB, which was formed in spring by merging nanoliter-scale immunoassay expert Gyros AB and peptide synthesis instrumentation and reagent provider Protein Technologies Inc., has a new chair. Frank Witney took over as Chairman of the Board of Directors in June.
Novozymes bags Organobalance
Latest NewsDenmark’s Novozymes has acquired microbial research company Organobalance GmbH. The German company owns a large collection of microbial strains, some of which date back to the 1920s, and has strong capabilities in microbial screening and assay technology.
AC Immune boldly prices Nasdaq IPO
Latest News14.09.2016 – The summer slump on the stock markets is over: AC Immune has confidently priced its long-awaited Nasdaq IPO. The Swiss Alzheimer’s specialist is expecting to raise up to US$68m (€60.5m) overseas.
Bioelectric pro
AppointmentsGalvani Bioelectronics, the developer of bioelectronic medicines launched by GlaxoSmithKline and Alphabet’s life science play Verily (formerly Google Life Sciences) in early August, will have a bioelectronic visionary on board. Moncef Slaoui, who expedited GSK investments in the field of bioelectronics, will be the chairman of the new company’s Board of Directors.
Sanofi, Google launch diabetes venture
Latest News13.09.2016 – Diabetes major Sanofi is joining forces with Verily – formerly Google Life Sciences – to launch Onduo. The joint venture will develop a comprehensive diabetes management platform.
Clinical development know-how
AppointmentsFrench biopharma company Pharnext has appointed René Goedkoop as its new Chief Medical Officer. He joins the neurodegenerative disease specialist from Swiss Shogu Consulting SarL.
Fresh French fund for healthcare
Latest News09.09.2016 – iBionext’s healthcare VC fund iBionext Growth has announced a first closing of €46m. All in all, iBionext aims to take in around €100m to reinvest in biotech and medtech companies.
Bed and board go bio-based
Latest News07.09.2016 – Furniture giant Ikea and renewables expert Neste have joined forces to deliver bio-based plastics based on Neste’s bio-based polymer. The partners urge other companies to join the initiative.
Immunotherapy pioneer
AppointmentsMatthias Schroff, erstwhile CEO of Mologen, has taken over the helm of immunotherapy developer Vaximm AG. The Swiss-German company appointed him Chief Executive Officer in early September.
Boosting vaccines without the prick
Latest News06.09.2016 – DBV’s needle-free patch technology is being put to the test in a a proof of concept trial for a pertussis vaccine developed by BioNet-Asia. Researchers from the Geneva University Hospital are supervising the study.